Target Cancer Metabolism
Translating cancer metabolism targets into effective therapies
29 January - 1 February 2013
Boston, MA
Attendees
Who should attend?
Industry Sectors
The agenda is specifically designed for those working in the following sectors:
| Cancer Metabolism | Oncology Drug Developers | Cancer Drug Discovery | Novel Cancer Therapeutics |
| Translational Science | Translational Oncology | Target Discovery | Metabolic Pathways |
Job Titles
Job titles likely to attend this event, include:
| Head of Translational Science | Cancer Metabolism | Head of Chemistry | Head of Biology |
| President of Oncology | Translational Oncology | Drug Product Development | Oncology Drug Development |
| Principal Scientist, Oncology | Director, Clinical Research | Pre-clinical Development | CSO |
| CEO | President | Vice President |